What the news says
TMO's better-than-expected earnings and revenue reflect operational strength in life sciences and diagnostics segments, directly relevant to investors tracking healthcare technology and biotech equipment suppliers.
07/23, 05:01 PM
Thermo Fisher reported Q2 adjusted EPS of $6.03 versus estimate of $5.72, and revenue of $11.99B versus estimate of $11.7B.
Thermo Fisher reported Q2 adjusted EPS of $6.03 versus estimate of $5.72, and revenue of $11.99B versus estimate of $11.7B.
Affected assets
financialjuice
07/23, 05:01 PM
Related updates
jin10 · 07/23, 10:24 PM
High impactWTI crude oil surged 7% intraday, breaking above $93/barrel; Brent crude rose over 5% to $95.31/barrel.
jin10 · 07/21, 10:18 PM
Market reactionPresident Trump said he would handle a possible Red Sea blockade if it occurs.